'The Global Market for Therapeutic Respiratory Devices Will be Worth $10.9bn by 2022' Predicts New Visiongain's Report

'The Global Market for Therapeutic Respiratory Devices Will be Worth $10.9bn by 2022' Predicts New Visiongain's Report PR Newswire LONDON, October 9, 2012 LONDON, October 9, 2012 /PRNewswire/ -- A new report by visiongain, a London-based business information provider, predicts that the global market for therapeutic respiratory devices will be worth $10.9bn by 2022. The market generated sales of $4.1bn in 2011. Key factors in the growth of this market will be the global aging population and the continued rise in chronic diseases and conditions such as obesity and diabetes, which continue to be considered significant risk factors in the development of several respiratory diseases. The therapeutic respiratory devices market is one of the fastest growing markets in the medical device industry. The market is currently comprised of innovative respiratory devices for the treatment of a wide range of disorders that include asthma, COPD, pulmonary fibrosis as well as sleep disorders such as Obstructive Sleep Apnea (OSA). Rodrigo Gutierrez Gamboa, healthcare industry analyst, says: "Technological advancements and patient demand for homecare products that are more compact and user-friendly have propelled the field of respiratory devices in recent years. Furthermore, research regarding the causes of many respiratory disorders as well as their associations with other chronic conditions continues to accelerate.